
Federal drug pricing reforms must protect innovation and NY's economy
Most Favored Nation (MFN) policies, which tie U.S. drug prices to those in foreign countries, risk discouraging research and limiting access to advanced therapies. MFN pricing models could negatively impact the Hudson Valley's growing life sciences …